Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.79 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TOP1 | P11387 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sorbitol SCHEMBL11519008 | 1.00 | LMNA (0.79) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| Mannitol SCHEMBL8671937 | 1.00 | LMNA (0.79) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| Galactitol SCHEMBL11516787 | 1.00 | LMNA (0.79) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| Mannitol SCHEMBL27259380 | 1.00 | LMNA (0.79) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| Sorbitol SCHEMBL232913 | 1.00 | LMNA (0.79) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| Sorbitol SCHEMBL9654601 | 1.00 | LMNA (0.79) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| Mannitol SCHEMBL28980943 | 1.00 | LMNA (0.79) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| Sorbitol SCHEMBL8145945 | 0.97 | LMNA (0.73) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| Mannitol SCHEMBL2785381 | 0.94 | LMNA (0.69) | LMNAL3MBTL1TDP1ALDH1A1KDM4E | |
| Mannitol SCHEMBL9580709 | 0.94 | LMNA (0.69) | LMNAL3MBTL1TDP1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117414735-A | Collagen composite product production equipment and process thereof | 河南健帝宠物营养科技发展有限公司 | 2024-01-19 | — | — | CN | claimed |
| EP-3197952-B1 | BIODEGRADABLE POLYMER RECYCLING | JOHNSON ANTHONY FRANCIS (GB) | 2023-10-18 | — | — | EP | claimed |
| CN-110255615-A | A method of using arsenic alkaline slag as waste antimony oxide, arsenate and soda ash | 长沙紫宸科技开发有限公司 | 2019-09-20 | — | — | CN | claimed |
| US-20170233543-A1 | BIODEGRADABLE POLYMER RECYCLING | AQUAPAK IP LTD (GB) | 2017-08-17 | — | — | US | claimed |
| EP-3197952-A1 | BIODEGRADABLE POLYMER RECYCLING | Johnson, Anthony Francis (GB) | 2017-08-02 | — | — | EP | claimed |
| WO-2016046520-A1 | BIODEGRADABLE POLYMER RECYCLING | JOHNSON ANTHONY FRANCIS (GB) | 2016-03-31 | — | — | WO | claimed |
| CN-104127464-A | Ophthalmic Blumea balsamifera oil preparation and preparation method thereof | UNIV GUIZHOU | 2014-11-05 | — | — | CN | claimed |
| US-20070087939-A1 | Biopolymer compositions and products thereof | PFIZER INC. | 2007-04-19 | — | — | US | claimed |
| EP-1735377-A1 | BIOPOLYMER COMPOSITIONS AND PRODUCTS THEREOF | Warner-Lambert Company LLC (US) | 2006-12-27 | — | — | EP | claimed |
| WO-2005092968-A1 | BIOPOLYMER COMPOSITIONS AND PRODUCTS THEREOF | WARNER-LAMBERT COMPANY LLC (US) | 2005-10-06 | — | — | WO | claimed |
| EP-1580229-A1 | Biopolymer compositons and products thereof | WARNER-LAMBERT COMPANY LLC (US) | 2005-09-28 | — | — | EP | claimed |
| WO-2001072684-B1 | PROCESS FOR THE PREPARATION OF POLYMORPH OF 4-(ARYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE DERIVATIVE | SUN PHARMACEUTICAL IND LTD (IN) | 2001-11-29 | — | — | WO | claimed |
| US-5698219-A | CONTAINING NONIONIC SURFACTANT | LABORATORIOS CUSI, S.A. (ES) | 1997-12-16 | — | — | US | claimed |
| CN-117414735-A | Collagen composite product production equipment and process thereof | 河南健帝宠物营养科技发展有限公司 | 2024-01-19 | — | — | CN | disclosed |
| EP-3197952-B1 | BIODEGRADABLE POLYMER RECYCLING | JOHNSON ANTHONY FRANCIS (GB) | 2023-10-18 | — | — | EP | disclosed |
| US-20220000772-A1 | SPECIALLY FORMULATED COMPOSITIONS OF INHALED NINTEDANIB AND NINTEDANIB SALTS | AVALYN PHARMA INC. | 2022-01-06 | — | — | US | disclosed |
| EP-0369474-A2 | Pharmaceutical composition for the treatment of cerebral edema | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1990-05-23 | — | — | EP | disclosed |
| EP-0211506-A1 | Heteropolysaccharide and its Production and use | MERCK & CO. INC. (US) | 1987-02-25 | — | — | EP | disclosed |
| US-4283492-A | STREPTOMYCES CULTURE PRODUCT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-08-11 | — | — | US | disclosed |
| US-4108807-A | REACTING A METALLATE WITH A PSEUDOHALIDE IN THE PRESENCE OF A PHENOL-SUBSTITUTED TERTIARY AMINE CATALYST | CHEMIC-ANLAGENBAU BISCHOFSHEIM GMBH (DE) | 1978-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220000772-A1 | SPECIALLY FORMULATED COMPOSITIONS OF INHALED NINTEDANIB AND NINTEDANIB SALTS | FGF2, FIBP, REN | LMNA 3273/4885L3MBTL1 3670/4885TDP1 4195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.